Seminario - Opportunities for Machine Learning coming from the world of Clinical Trial Imaging and the Pharma Industry

il giorno 11 Maggio 2018 alle ore 17:00 presso il Dipartimento di Matematica e Informatica (Aula 23), Andrea Cherubini di Linkverse (http://www.linkverse.com/) terrà un seminario dal titolo “Opportunities for Machine Learning coming from the world of Clinical Trial Imaging and the Pharma Industry”.

Il seminario avrà luogo  e fa parte delle attività del corso di Machine Learning (Laurea in Informatica – Magistrale) e delle attività di collaborazione instaurate dal gruppo IPLAB con l’azienda.
Maggiori dettagli sul talk, sullo speaker e sull’azienda sono riportate sotto.

The Talk: 
Opportunities for Machine Learning coming from the world of Clinical Trial Imaging and the Pharma Industry.

In his talk, Andrea will provide a brief introduction to Linkverse company and vision. He will then describe the challenges encountered in the analysis and management of medical images in clinical trials, and the different perspectives of sponsors and regulatory bodies. In this context, he will report some examples on the solutions in the field of machine learning and artificial intelligence that Linkverse is providing.

The speaker: 
Andrea Cherubini, PhD, is the head of AI division at Linkverse. He has a long experience of research in the field of biomedical imaging in both Academia and Industry. He has been a Researcher of the Italian National Research Council and a serial entrepreneur of high-tech startups. 

The Company:
Linkverse is a company providing cutting edge services for biomedical imaging. It has successfully designed, implemented and deployed hardware and software development projects in the clinical research environment. Linkverse has a long experience in the management and analysis of biomedical data in clinical trials. Currently it is focused on the development of clinical decision support software to be registered as medical device under FDA regulation.